ABOUT THIS FUND
This investment product primarily channels its resources, typically committing a minimum of 95% of its net assets, into American Depositary Receipts (ADRs) that represent the B Shares of Novo Nordisk A/S. It's crucial to understand that direct investment in the company's underlying shares is not part of this series' strategy. Additionally, the fund is structured as non-diversified, indicating a concentrated portfolio.
PRICE
$21.82 ▼ DOWN 0.60% (−$0.13)HOLDINGS
TOP 1 OF 1 · 96.84% OF THE FUNDRANK STOCK WEIGHT SHARES VALUE
